close
Advertisement
Can't connect right now! retry

add The News to homescreen

tap to bring up your browser menu and select 'Add to homescreen' to pin the The News web app

Got it!

add The News to homescreen

tap to bring up your browser menu and select 'Add to homescreen' to pin the The News web app

Got it!
AFP
April 14, 2021

No ‘significant impact’ from J&J vaccine pause

World

AFP
April 14, 2021

WASHINGTON: The White House on Tuesday played down the impact of a decision to pause the rollout of Johnson & Johnson’s Covid-19 vaccine on the wider US vaccination effort.

“This announcement will not have a significant impact on our vaccination plan: Johnson & Johnson vaccine makes up less than five percent of the recorded shots in arms in the United States to date,” said Jeff Zients, President Joe Biden’s Covid-19 response coordinator, in a statement.

Zients said the huge surplus in supplies of two other vaccines — Pfizer and Moderna — meant the United States could easily take up the slack after Johnson & Johnson was forced to suspend due to safety concerns.

“Over the last few weeks, we have made available more than 25 million doses of Pfizer and Moderna each week,” Zients said. “This is more than enough supply to continue the current pace of vaccinations of three million shots per day and meet the president’s goal of 200 million shots by his 100th day in office.”

However, with swaths of the population — especially Republican men — already hesitant to take vaccines, the J&J setback could further threaten the public relations campaign.